Scientists identify new target for melanoma immunotherapy. – Brinkwire

QIMR Berghofer research has found a new reason why some melanoma patients do not respond well to immunotherapya discovery that could lead to better-tailored treatments for the potentially deadly canc…

Click here to view the original article.